Recent News

• 02.21.2025 - Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
• 02.21.2025 - Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
• 02.21.2025 - Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
• 01.13.2025 - 43rd Annual J.P. Morgan Healthcare Conference
• 01.13.2025 - Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
• 01.13.2025 - Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
• 01.13.2025 - Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Recent Filings

• 02.21.2025 - EX-99.1 EX-99.1
• 02.21.2025 - 8-K Current report
• 02.21.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.18.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 02.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities